Back to UBS Group AG UBS Group AG

RNLXYRNLXY
16 quarters

Position history for UBS Group AGUBS Group AG's holdings in RENALYTIX PLC

UBS Group AG previously held 0 shares of RNLXY (RENALYTIX PLC), worth $0 as of 2024-Q4.

Final Value

$0

Final Shares

0

Total Value Change

-$11,000

Total Shares Change

-659

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2024-Q4
Latest
Exited
0
-100.0%
$00.0%$127.50
0
2024-Q3
Increased
279,743
+3729x
$58,4660.0%$163.75
23
2024-Q2
New
75
-
$170.0%$144.38
17
2023-Q4
Exited
0
-100.0%
$00.0%$243.75
0
2023-Q3
Decreased
4,061
-36.6%
$6,4980.0%$1,000.00
0
2023-Q2
Increased
6,410
+2651.1%
$18,7170.0%$1,293.75
20
2023-Q1
Decreased
233
-97.1%
$5640.0%$1,406.25
0
2022-Q4
Increased
7,960
+430.7%
$14,8850.0%$1,168.75
20
2022-Q3
Increased
1,500
+200.0%
$2,0000.0%$806.25
12
2022-Q2
Decreased
500
-16.7%
$1,0000.0%$2,481.25
0
2022-Q1
Decreased
600
-80.9%
$4,0000.0%$4,456.25
0
2021-Q4
Increased
3,143
+109.5%
$50,0000.0%$10,175.00
23
2021-Q3
Decreased
1,500
-73.2%
$30,0000.0%$12,181.25
0
2021-Q2
Increased
5,600
+180.0%
$173,0000.0%$19,306.25
36
2021-Q1
Increased
2,000
+203.5%
$51,0000.0%$15,937.50
23
2020-Q4
New
659
-
$11,0000.0%$9,100.00
26

Other major holders of RNLXY: GILDER GAGNON HOWE & CO LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used